BBOT
BridgeBio Oncology Therapeutics, Inc.
3.90$
-3.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | +29.9% | +65.8% | |
| – | -95.3% | +240,951.1% | -8.6% | +217.4% | |
| – | -91.9% | +1,839,985.2% | +24.8% | +80.3% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.